Hemant Surgical Industries Ltd
BSE:543916
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
IN |
|
Novem Group SA
XETRA:NVM
|
LU |
|
A
|
Anheuser-Busch Inbev SA
SWB:1NBA
|
BE |
Balance Sheet
Balance Sheet Decomposition
Hemant Surgical Industries Ltd
Hemant Surgical Industries Ltd
Balance Sheet
Hemant Surgical Industries Ltd
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
36
|
15
|
58
|
85
|
4
|
95
|
|
| Cash |
0
|
0
|
0
|
0
|
4
|
0
|
|
| Cash Equivalents |
36
|
15
|
58
|
85
|
0
|
95
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
110
|
52
|
|
| Total Receivables |
80
|
64
|
180
|
222
|
304
|
332
|
|
| Accounts Receivables |
54
|
43
|
157
|
172
|
217
|
204
|
|
| Other Receivables |
26
|
22
|
23
|
50
|
86
|
128
|
|
| Inventory |
148
|
148
|
128
|
148
|
255
|
455
|
|
| Other Current Assets |
24
|
28
|
10
|
12
|
20
|
30
|
|
| Total Current Assets |
288
|
256
|
376
|
467
|
693
|
888
|
|
| PP&E Net |
102
|
119
|
116
|
132
|
177
|
518
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
177
|
518
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
64
|
72
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
41
|
42
|
44
|
45
|
36
|
36
|
|
| Long-Term Investments |
12
|
12
|
8
|
4
|
49
|
13
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
0
|
12
|
29
|
|
| Total Assets |
443
N/A
|
429
-3%
|
544
+27%
|
647
+19%
|
966
+49%
|
1 483
+53%
|
|
| Liabilities | |||||||
| Accounts Payable |
170
|
127
|
207
|
242
|
246
|
390
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
22
|
34
|
|
| Current Portion of Long-Term Debt |
63
|
41
|
57
|
41
|
11
|
43
|
|
| Other Current Liabilities |
61
|
59
|
106
|
94
|
100
|
146
|
|
| Total Current Liabilities |
294
|
227
|
370
|
377
|
378
|
613
|
|
| Long-Term Debt |
75
|
103
|
41
|
31
|
35
|
233
|
|
| Deferred Income Tax |
0
|
0
|
1
|
3
|
1
|
0
|
|
| Other Liabilities |
2
|
2
|
3
|
3
|
4
|
5
|
|
| Total Liabilities |
371
N/A
|
333
-10%
|
414
+24%
|
413
0%
|
418
+1%
|
851
+104%
|
|
| Equity | |||||||
| Common Stock |
20
|
20
|
20
|
77
|
104
|
104
|
|
| Retained Earnings |
52
|
64
|
110
|
157
|
255
|
338
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
189
|
189
|
|
| Other Equity |
0
|
13
|
0
|
0
|
0
|
0
|
|
| Total Equity |
72
N/A
|
96
+33%
|
130
+35%
|
234
+80%
|
549
+135%
|
632
+15%
|
|
| Total Liabilities & Equity |
443
N/A
|
429
-3%
|
544
+27%
|
647
+19%
|
966
+49%
|
1 483
+53%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
|